Bruker (BRKR) Liabilities and Shareholders Equity (2010 - 2026)

Bruker (BRKR) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $6.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 4.53% year-over-year to $6.1 billion; the trailing twelve-month figure through Jun 2026 stood at $24.9 billion (up 2.76% YoY), and the FY2025 full-year result was $6.2 billion, up 7.49% from the prior year.
• Liabilities and Shareholders Equity declined to $6.1 billion in Q2 2026 per BRKR's latest filing, from $6.1 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q3 2025 and bottomed at $3.3 billion in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $4.9 billion across 5 years, with a median of $5.2 billion in 2024.
• The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity soared 60.04% in 2024, then fell 4.53% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $3.6 billion in 2022, then climbed by 17.67% to $4.2 billion in 2023, then soared by 36.63% to $5.8 billion in 2024, then grew by 7.49% to $6.2 billion in 2025, then declined by 3.02% to $6.1 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $6.1 billion, $6.1 billion, and $6.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.